# A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

> **NCT01376297** · PHASE3 · COMPLETED · sponsor: **Helsinn Healthcare SA** · enrollment: 413 (actual)

## Conditions studied

- Chemotherapy-Induced Nausea and Vomiting

## Interventions

- **DRUG:** Netupitant and Palonosetron
- **DRUG:** Aprepitant
- **DRUG:** Palonosetron
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01376297
- **Lead sponsor:** Helsinn Healthcare SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-09
- **Final completion:** —
- **Target enrollment:** 413 (ACTUAL)
- **Last updated:** 2014-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376297, "A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01376297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*